Kao, S.C-H.
3028  Ergebnisse:
Personensuche X
?
2

148P AdvanTIG-105: Phase Ib dose-expansion study of ociperl..:

Zhang, J. ; Hussein, M. ; Kao, S.C-H....
Immuno-Oncology and Technology.  16 (2022)  - p. 100260 , 2022
 
?
3

126P AdvanTIG-105: Phase Ib dose-expansion study of ociperl..:

Frentzas, S. ; Meniawy, T. ; Kao, S.C-H....
Immuno-Oncology and Technology.  16 (2022)  - p. 100238 , 2022
 
?
4

Comment on 'Existing prognostic models, but not neutrophil-..:

Kao, S C-H ; van Zandwijk, N ; Clarke, S
British Journal of Cancer.  111 (2014)  12 - p. 2376-2376 , 2014
 
?
5

Second‐line therapy for castrate‐resistant prostate cancer:..:

KAO, S C‐H ; HOVEY, E ; MARX, G
Asia-Pacific Journal of Clinical Oncology.  7 (2011)  3 - p. 212-223 , 2011
 
?
 
?
8

Validity of the American College of Surgeons' National Surg..:

Kao, S S ; Frauenfelder, C ; Wong, D...
The Journal of Laryngology & Otology.  132 (2017)  2 - p. 173-179 , 2017
 
?
9

A comparison of oncological outcomes between transoral surg..:

Kao, S S ; Micklem, J ; Ofo, E...
The Journal of Laryngology & Otology.  132 (2017)  4 - p. 349-355 , 2017
 
?
 
?
12

A decision support system for locating convenience store th..:

Kuo, R.J. ; Chi, S.C. ; Kao, S.S.
Computers & Industrial Engineering.  37 (1999)  1-2 - p. 323-326 , 1999
 
?
 
1-15